关于我们
NOTA develops an expanding portfolio of therapeutics that leverage the therapeutic properties of nitric oxide. NOTA is focused on developing affordable proprietary Nitric Oxide (NO) delivery platform technologies for hospital and in-home use that treat many life-threatening diseases, including viral and bacterial respiratory infections such as bronchiolitis, COVID-19, and pneumonia, use in open-heart surgery, heart attacks, and strokes, and the treatment of neonates born with underdeveloped lungs.
- 网站
-
https://www.notalabs.com
NOTA Laboratories的外部链接
- 所属行业
- 生物技术研究
- 规模
- 11-50 人
- 总部
- Ann Arbor，Michigan
- 类型
- 私人持股
- 创立
- 2015
地点
-
主要
获取路线
600 S Wagner Road
Suite 6
US，Michigan，Ann Arbor，48103-9002